Home > Blog Tag

Blog Posts by Tag: Molecular

Molecular Diagnostic Market-Share Expansion: Keys to Success

The molecular diagnostics market has experienced tremendous growth in recent years. It’s a complex business with many challenges, including prior authorization requirements, diagnostic coding changes, the evolving regulatory landscape, and specimen collection moving from physician offices and laboratories to the home. Growing and scaling a successful molecular diagnostics business requires...

Read


Top 5 Blog Posts of 2022

As always, XIFIN’s Beyond Billing blog kept abreast of key issues and hot topics within the healthcare industry, staying especially in tune with legislative proposals that can potentially impact reimbursement and revenue.Here are the top blogs of 2022, with far-ranging topics that include PAMA and SALSA, the No Surprises Act, digital pathology, and revenue cycle management. 1. Laboratory Test...

Read


It’s Important to Know How Your LIS Stacks Up. Take This Survey to Find Out.

The laboratory information system (LIS) plays a vital role in diagnostics. The LIS is the workhorse of the lab and is vital to day-to-day workflow and functionality. This essential system supports operational efficiency, testing capacity, timely specimen reporting, analytics, and business reporting.Many labs continue to use homegrown or on-premise systems that do not take advantage of the many...

Read


Take a Long, Hard Look at Your LIS

Laboratory testing is always changing with new technologies and ever-expanding test menus that have complex requirements around reporting, authorizations, reimbursements, and specimen processing. All of these changes impact your laboratory information system (LIS). To thrive in this dynamic environment, you need an LIS that can keep up with industry changes, throughput requirements, user...

Read


Considerations When Selecting an LIS for Gynecologic Cytology and Molecular Testing

Laboratories leaders investigating LIS solutions for Gynecologic Cytology and Molecular testing need dynamic solutions that meet all productivity and efficiency goals and regulatory requirements. Other essential factors include cytotech reporting, automated quality control review and reporting, pathology oversight and reporting, Bethesda reporting guidelines, management reporting, lookback...

Read


Laboratory Test Claim Denials and Appeals Trends

I recently had the privilege of presenting an in-person workshop in conjunction with The Dark Report Executive War College on Laboratory and Pathology Management. The workshop was on the topic of “Latest Trends and Denials Involving Lab Test Claims.” In this session, I shared XIFIN insights into payor behavior changes and shifting claims processing protocols and highlighted the importance of a...

Read


Pathology Laboratories Need Unique LIS Capabilities

Anatomic pathology laboratories receive multiple specimen types including pathology, IHC, molecular, next-gen sequencing, FLOW, cytogenetics, FISH, clinical trials, and specialty testing. This is why anatomic pathology laboratories require a sophisticated laboratory information system (LIS) with enhanced capabilities that can manage everything from routine to highly complex cases. The right...

Read


Three Questions You Should Be Asking to Determine if the No Surprises Act Applies to You

How do the billing protections established under the No Surprises Act impact my group?This is what everyone is asking. It’s a very complex question that isn’t answered with a simple yes or no. However, listed below are three questions you should ask to determine if any of your services are impacted by the No Surprise Act legislation.*  Is the...

Read